• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Sanofi-Aventis ADR

Sanofi-Aventis ADR

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Seasonal Influenza Vaccines KOL Interviews 2017 - Vaccines discussed are Fluad, FluBlok, Flucelvax, FluMist Quadrivalent (AZN), Fluzone High Dose (SNY ) and Intanza (SNY ). - Research and Markets

    Seasonal Influenza Vaccines KOL Interviews 2017 - Vaccines discussed are Fluad, FluBlok, Flucelvax, FluMist Quadrivalent (AZN), Fluzone High Dose ( SNY ) and Intanza ( SNY ). - Research and Markets

  2. An Outstanding Large-Cap Fund for Patient Investors

    Gold-rated Dodge & Cox Stock’s seasoned team, low fees, and decisive value approach have led to enviable long-term results.

  3. Sanofi to Buy Vaccine Company Firm Protein Sciences

    Sanofi to Buy Vaccine Company Firm Protein Sciences

  4. This ETF Delivers a Bundle of S&P 500 Healthcare Stocks at a Reasonable Price

    Health Care Select Sector SPDR boasts a portfolio full of wide-moat names and a competitive price tag.

123

©2017 Morningstar Advisor. All right reserved.